Celldex Therapeutics Inc CLDX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/13/24 EDT
40.11UNCH (UNCH)
Volume
60,447
Close
40.11UNCH (UNCH)
Volume
311,931
52 week range
22.11 - 53.18
Loading...
  • Open40.38
  • Day High40.81
  • Day Low39.95
  • Prev Close40.11
  • 52 Week High53.18
  • 52 Week High Date03/04/24
  • 52 Week Low22.11
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap2.644B
  • Shares Out65.91M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change1.13

KEY STATS

  • Open40.38
  • Day High40.81
  • Day Low39.95
  • Prev Close40.11
  • 52 Week High53.18
  • 52 Week High Date03/04/24
  • 52 Week Low22.11
  • 52 Week Low Date10/30/23
  • Market Cap2.644B
  • Shares Out65.91M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change1.13

RATIOS/PROFITABILITY

  • EPS (TTM)-2.84
  • P/E (TTM)-14.10
  • Fwd P/E (NTM)-16.15
  • EBITDA (TTM)-147.122M
  • ROE (TTM)-25.39%
  • Revenue (TTM)6.072M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,385.97%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Celldex Therapeutics Inc

 

Profile

MORE
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is...
Karen Shoos
Non-Executive Independent Chairman of the Board
Anthony Marucci
President, Chief Executive Officer, Director
Sam Martin CPA
Chief Financial Office, Senior Vice President, Secretary
Tibor Keler Ph.D.
Executive Vice President, Chief Scientific Officer
Address
53 Frontage Road, Suite 220
Hampton, NJ
08827
United States

Top Peers

SYMBOLLASTCHG%CHG
MLTX
MoonLake Immunotherapeutics
41.71UNCHUNCH
MRUS
Merus NV
45.85UNCHUNCH
RNA
Avidity Biosciences Inc
26.02UNCHUNCH
ARWR
Arrowhead Pharmaceuticals Inc
22.06UNCHUNCH
IDYA
IDEAYA Biosciences Inc
41.07UNCHUNCH